InVivo Therapeutics Holdings Corp (NVIV) Stock
NVIV is no longer traded. InVivo Therapeutics Holdings was delisted from the Nasdaq in February 2024.
Prices on this page are historical; the last trade was February 12, 2024 at $0.32.
InVivo Therapeutics Holdings stock price history
NVIV final trading statistics
- Final close
- $0.32
- Final trading day
- Feb 12, 2024
- Market cap at delisting
- $995.9K
- Shares outstanding
- 3.11M
- Final 52-week range
- $0.22 – $2.40
- Avg. volume (final 3 mo.)
- 3,801,010
- All-time high (split-adj.)
- $425250.00 · Jul 2013
- All-time low (split-adj.)
- $0.22 · Feb 2024
- Return since IPO
- -100.0%
- Beta
- 0.66
- Book value / share
- $2.87
- Price / book
- 0.11
InVivo Therapeutics Holdings annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $0.00 | -$9.3M | -$2.34 |
| FY2022 | $0.00 | -$10.2M | -$13.11 |
| FY2021 | $0.00 | -$9.9M | -$31.92 |
| FY2020 | $0.00 | -$9.1M | -$31.92 |
| FY2019 | $0.00 | -$12.2M | -$882.00 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About InVivo Therapeutics Holdings Corp
InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.
InVivo Therapeutics Holdings stock FAQ
What happened to InVivo Therapeutics Holdings stock?
InVivo Therapeutics Holdings stock was delisted from the Nasdaq. Its final close was $0.32 on February 12, 2024.
Is NVIV stock still trading?
No. NVIV was delisted from the Nasdaq in February 2024 and no longer trades on a U.S. exchange.
What was the last price of NVIV stock?
NVIV closed at $0.32 on its final trading day, February 12, 2024, for a market value of about $995.9K.
What were InVivo Therapeutics Holdings's revenue and earnings in its last full fiscal year?
InVivo Therapeutics Holdings reported revenue of $0.00 and net income of -$9.3M in fiscal 2023, its last full year as a public company.
When did InVivo Therapeutics Holdings go public?
InVivo Therapeutics Holdings Corp stock began trading on October 29, 2010.